01:14:17 EDT Tue 23 Jul 2019
Enter Symbol
or Name
USA
CA



Lotus Ventures Inc
Symbol C : J
Shares Issued 55,555,750
Close 2018-02-08 C$ 0.56
Recent Sedar Documents

ORIGINAL: Lotus Ventures' LP application in active review

2018-02-08 20:44 ET - News Release

Received by email:

File: Lotus Ventures Health Canada & $1MM Financing News Release Feb 8 2018 f.pdf

         NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR
                  DISSEMINATION IN THE UNITED STATES




Suite 1010   1030 West Georgia Street, Vancouver, British Columbia V6E 2Y3

Canadian Securities Exchange: Symbol J

Vancouver, British Columbia   February 8, 2018



LOTUS   ENTERS "ACTIVE REVIEW" WITH HEALTH CANADA & CLOSES
              CANNABIS FINANCING OF $1 MILLION.

Lotus Ventures Inc (CSE: J) (the "Company") announced today that its licensed producer
application for its Armstrong, BC purpose-built indoor facility (the "Application") under
the Access to Cannabis for Medical Purposes Regulations ("ACMPR") is currently in
"active review". Following the successful completion of Health Canada's paper review of
the Application, the Company will be required to submit an evidence package
demonstrating that the purpose-built indoor facility is a functioning facility that adheres to
the ACMPR.

In conjunction with this announcement, the Company is pleased to confirm that its partner,
Cannabis Wheaton Income Corp. ("CBW") has subscribed, by way of a private placement,
for 1,818,181 units (each a "Unit") in the capital of the Company at a price per Unit of
$0.55 (the "Subscription") for aggregate proceeds of $1,000,000. Each Unit consists of
one common share of the Company and one-half of one common share purchase warrant
(each whole warrant, a "Warrant"). Each Warrant is exercisable into one common share
in the capital of the Company for a period of 36 months from the date of issue, at an exercise
price of $1.00 per Warrant. Concurrently with the Subscription, the Company and CBW
have amended and restated their original interim agreement to decrease the initial financial
commitment of CBW by an aggregate amount of $1,000,000.

"Both these announcements are material milestones for the company and our shareholders.
We are very pleased to be working with CBW on our future expansion plans," said Dale
McClanaghan, CEO of Lotus Ventures, Inc.

Hugo Alves, President of CBW, stated, "We want to congratulate our streaming partner
Lotus on their progress towards licensing. We're excited to invest in Lotus and we believe
that they have a unique approach to indoor cultivation and a management team that can
successfully scale up their operations."
 ON BEHALF OF THE BOARD
Lotus Ventures Inc.
"Dale McClanaghan"
Dale McClanaghan, President and CEO

About Lotus Ventures, Inc.

Lotus is a late stage licensed producer ("LP") applicant under the ACMPR rules and
regulations, in active review with Health Canada. The unique business model combines an
upstream royalty financing model with CBW and a downstream licensing model with
farmer/grower partners using Lotus technology and intellectual property. The first facility
is currently under construction in Armstrong, B.C. It is a purpose built, "state of the art"
indoor facility with proprietary processes. The company has previously announced its first
farmer/grower partner with its second facility slated in Ontario. See our December 14, 2017
press release for more details. The Lotus approach enables a scalable and reliable low-cost,
high quality production at our BC facilities and our national partners.

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com (604) 644-
9844 or Daniel McRobert, Communications danielmcrobertt@gmail.com (604) 842-4625

About Cannabis Wheaton Income Corp.

CBW is a collective of entrepreneurs with a passion for the cannabis industry past, present
and future. CBW's mandate is to facilitate growth for our partners by providing them with
financial support and sharing our collective industry experience. CBW's partners all have
different visions, voices and brand values, and all share a common goal--to build a world-
class industry based on ethics, diversity, quality and innovation.
 


© 2019 Canjex Publishing Ltd. All rights reserved.